Managing Partner
| |
Learn more about Partnership for Prevention's initiatives here.
|
Find the NCC on Facebook!
The National Chlamydia Coalition is now on Facebook. To follow the NCC, simply visit our page and click the "like" button. Don't forget to share it with your friends and colleagues!
| |
|
|
|
Dear Colleague,
Welcome to NCC News. This online newsletter was created to keep you up-to-date on all things chlamydia and related areas of interest. We hope you will find it useful and informative. Please feel free to share this with your colleagues who also may find it of use. |
 |
Guide to Quality Improvement Using the Chlamydia Screening HEDIS Measure: Webinar Series
|
The National Chlamydia Coalition, in collaboration with the National Committee for Quality Assurance (NCQA), developed a three-part webinar series designed to provide participants with a guide to improve the quality of care and services using the chlamydia screening HEDIS measure. The third, and final, session of the series, Tools to Address Preserving Confidentiality, Providing Services to Adolescents and Talking with Parents, will be held on March 4th from 2:00-3:30 PM ET. At the conclusion of session 3, you will be able to: 1) Review laws and policies governing confidentiality of sensitive services; 2) Discuss options for maintaining confidentiality with explanation of benefits and billing; 3) Discuss specific tools for clinics and providers to become adolescent friendly; 4) Provide examples of tools and tips for talking with parents, and; 5) Identify educational materials and resources that health plans may use for patients, parents, and providers. Registration is $149.
|
 |
Differences in Contraceptive Use Between Providers and the US Population
|
A new study shows what methods of birth control method US family planning providers are most likely to use themselves, and compares that to what methods are most popular among US women overall. Researchers surveyed a sample of female family planning providers ages 25-44 via an online survey in 2013. A total of 488 responses were eligible for analysis and compared to female respondents ages 25-45 from the 2011-2013 National Survey of Family Growth. Over 41% of providers report using an IUD, as compared to only 12% of women in the general population. Providers were also more likely to use the vaginal ring than women in the general population (11% compared to 2%). Partner vasectomy and the pill were used by providers and US women at about the same rate. These findings may reflect differences in preference and access and may have implications for clinical practice, patient education, and health policy.
|
 |
New Study on Patient-Delivered Partner Therapy
|
Promoting the use of free patient-delivered partner therapy (PDPT) substantially increased its use and may have resulted in a decrease in chlamydia and gonorrhea infections, according to a new study. The study made PDPT available to clinicians, and provided public health partner services based on clinician referral. Heterosexual individuals with gonorrhea or chlamydia were eligible for the intervention. The intervention increased the percentage of persons receiving PDPT from clinicians from 18% to 34%, and the percentage receiving partner services from 25% to 45%. The intervention was also associated with an approximately 10% reduction in both chlamydia positivity and gonorrhea incidence.
|
 | New Comprehensive Guide on Adolescent Sexual Health Available |
The Youth Providers 2.0 initiative, a collaboration between SAHM and Columbia University Mailman School of Public Health, released of a compilation of Sexual and Reproductive Health Clinical Care Resources intended to provide guidance and resources for adolescent and young adult health care providers and youth serving professionals. It includes clinical care guidelines and resources that are free of cost; specific to adolescents or regarding a population which includes adolescents; open access or accessible after the creation of a free login; and nationally applicable.
|
 |
HPV Vaccination Not Associated with Increased STD Rates
|
According to a study, published in JAMA Internal Medicine, the HPV vaccine is not associated with increased STD rates. Researchers analyzed an insurance database of young girls ages 12 to 18 from 2005 through 2010 to examine STD rates among girls who were vaccinated and those who were not. The data set included more than 21,600 girls who received the HPV vaccine and 186,500 girls who were not vaccinated. Study results indicated that vaccinated females had higher rates of STDs before and after vaccination compared with those who were nonvaccinated. However, there was no significant difference in the growth of STD rates between the two groups in the year following vaccination, leading researchers to conclude that the HPV vaccine is not likely associated with an increase in unsafe sexual behavior.
|
 |
New Sexual Health Toolkits Available for Education Agencies
|
|
 |
Just Text Me!
|
This study, published in Sexually Transmitted Diseases, evaluates the Florida Department of Health STD Program's use of providing test results through text message. The study examines client uptake and completion of texting and whether texting was associated with a shorter treatment period. From February 2012 to January 2013, 10,272 clients were offered texting, and 52% opted in. Among texters who were positive and had not been treated, 57% called back. Texters received treatment in 5.1 days, and nontexters received treatment in 6.7 days. Researchers concluded thattexting offers STD programs an alternative to traditional notification procedures and may be a viable option for STD programs to reduce the use of staff resources and increase timely treatment for clients.
|
 |
New Smartphone Accessory Detects HIV & Syphilis in Minutes
|
A new smartphone dongle, developed by engineers at Columbia
 University, can detect HIV and syphilis in just 15 minutes. The dongle, which plugs in to the audio jack, replicates traditional lab-based diagnostics for the HIV antibody, as well as two markers for syphilis, in a single-test format. Researchers found the technology was 92 to 100 percent accurate for sensitivity, or tests that were true-positive, and 79 to 100 percent accurate for specificity, or tests that are true-negative. The accessory tests for syphilis and HIV in particular because they are two serious infections that can be passed from mother to child in the womb, but it also has the potential to test for other STDs and markers, such as cancer markers and diabetic markers.
|
|
|
|